Skip to content

Study · Not a test of the peptide alone · 2011

1 result

Structure-activity relationships of GHRP-6 azapeptide ligands of the CD36 scavenger receptor by solid-phase submonomer azapeptide synthesis.

Sabatino D, Proulx C, Pohankova P, Ong H, Lubell WD

Journal of the American Chemical Society21 Jul 2011Cited by 44 (Europe PMC)

PMID21692501 (opens in a new tab)DOI10.1021/ja203007u (opens in a new tab)PepBankPUB-21692501
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01LabNot a test of GHRP-6 aloneIn vitro (cell-free)Activity measurement

    In competition binding studies with hexarelin as the radiotracer ligand, certain [aza-Glu]GHRP‑6 azapeptide analogs kept relatively high affinity for the CD36 scavenger receptor.

    In plain wordsIn lab tests, certain modified GHRP‑6 analogs kept fairly strong binding to the CD36 receptor.

    Peptide
    GHRP-6
    Outcome
    Not applicableCD36 binding affinity of [aza-Glu]GHRP-6 analogs
    Study

    n: not reported in source

    in vitro competition binding to CD36
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Measurements

    CD36 binding affinity
    2 to 27 μM
    [aza-Glu]GHRP-6 azapeptides

    Source sentences

    Summary
    In covalent competition binding studies with the GHRP-6 prototype hexarelin bearing a radiotracer, certain [aza-Glu]GHRP-6 azapeptides retained relatively high (2-27 μM) affinity for the CD36 scavenger receptor.

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 2

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.